OA12810A - Tolterodine 12 salts. - Google Patents
Tolterodine 12 salts. Download PDFInfo
- Publication number
- OA12810A OA12810A OA1200400285A OA1200400285A OA12810A OA 12810 A OA12810 A OA 12810A OA 1200400285 A OA1200400285 A OA 1200400285A OA 1200400285 A OA1200400285 A OA 1200400285A OA 12810 A OA12810 A OA 12810A
- Authority
- OA
- OAPI
- Prior art keywords
- acid
- sait
- hydroxytolterodine
- pharmaceutically acceptable
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/127,875 US7005449B2 (en) | 2002-04-23 | 2002-04-23 | Tolterodine salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12810A true OA12810A (en) | 2006-07-11 |
Family
ID=29215346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200400285A OA12810A (en) | 2002-04-23 | 2003-04-22 | Tolterodine 12 salts. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7005449B2 (ko) |
| EP (1) | EP1496882B1 (ko) |
| JP (1) | JP2005535578A (ko) |
| KR (1) | KR20040104585A (ko) |
| CN (1) | CN1646110A (ko) |
| AP (1) | AP2004003160A0 (ko) |
| AT (1) | ATE334665T1 (ko) |
| AU (1) | AU2003237724A1 (ko) |
| BR (1) | BR0309439A (ko) |
| CA (1) | CA2483092A1 (ko) |
| DE (1) | DE60307258T2 (ko) |
| EA (1) | EA200401108A1 (ko) |
| EC (1) | ECSP045373A (ko) |
| ES (1) | ES2266828T3 (ko) |
| HR (1) | HRP20040990A2 (ko) |
| IL (1) | IL164109A0 (ko) |
| IS (1) | IS7462A (ko) |
| MA (1) | MA27197A1 (ko) |
| MX (1) | MXPA04010472A (ko) |
| NO (1) | NO20044449L (ko) |
| OA (1) | OA12810A (ko) |
| PL (1) | PL371743A1 (ko) |
| TN (1) | TNSN04212A1 (ko) |
| TW (1) | TW200306802A (ko) |
| WO (1) | WO2003090734A1 (ko) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05002302A (es) * | 2002-08-28 | 2005-06-08 | Pharmacia Corp | Composicion liquida oral de tolterodina. |
| US7393874B2 (en) * | 2003-04-08 | 2008-07-01 | Hetero Drugs Limited | Polymorphs of tolterodine tartrate |
| MXPA05011225A (es) * | 2003-04-18 | 2005-12-14 | Pharmacia & Upjohn Co Llc | Politerapias. |
| JP5250205B2 (ja) * | 2003-12-24 | 2013-07-31 | シプラ・リミテッド | トルテロジン、その組成物及び使用、及びその製造方法 |
| EP1629834A1 (en) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Sustained release pharmaceutical composition of tolterodine |
| ITMI20060110A1 (it) * | 2006-01-24 | 2007-07-25 | Dipharma Spa | Procedimento per la purificazione di tolterodina |
| US8486452B2 (en) | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
| US8871275B2 (en) | 2007-08-08 | 2014-10-28 | Inventia Healthcare Private Limited | Extended release compositions comprising tolterodine |
| KR101188333B1 (ko) * | 2008-02-20 | 2012-10-09 | 에스케이케미칼주식회사 | 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염 |
| US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
| ITMI20082055A1 (it) * | 2008-11-19 | 2009-02-18 | Dipharma Francis Srl | Procedimento per la preparazione di (r)-tolterodina base libera |
| KR20120014583A (ko) * | 2009-05-11 | 2012-02-17 | 라티오팜 게엠베하 | 타르타르산 염 형태의 데스페소테로딘 |
| IT1396373B1 (it) * | 2009-10-29 | 2012-11-19 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina. |
| IT1403094B1 (it) | 2010-12-09 | 2013-10-04 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina o un suo sale |
| GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
| CA3103995A1 (en) | 2018-07-26 | 2020-01-30 | Sumitomo Dainippon Pharma Oncology, Inc. | Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same |
| CN111728957B (zh) * | 2020-07-06 | 2022-04-19 | 济南大学 | 一种托特罗定长效缓释微球及其制备方法 |
| CN111925294A (zh) * | 2020-07-06 | 2020-11-13 | 济南大学 | 一种托特罗定帕莫酸盐及其制备方法 |
| CN115814090B (zh) * | 2022-11-22 | 2024-05-24 | 广州医科大学附属第一医院 | 烟草引发炎症的药物靶点 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5382600A (en) | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
| SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
| KR20000057548A (ko) | 1996-12-13 | 2000-09-25 | 알프레드 엘. 미첼슨 | 광학적 전송물질 및 결합재 |
| PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
-
2002
- 2002-04-23 US US10/127,875 patent/US7005449B2/en not_active Expired - Fee Related
-
2003
- 2003-04-22 EP EP03736380A patent/EP1496882B1/en not_active Expired - Lifetime
- 2003-04-22 JP JP2003587370A patent/JP2005535578A/ja active Pending
- 2003-04-22 CA CA002483092A patent/CA2483092A1/en not_active Abandoned
- 2003-04-22 ES ES03736380T patent/ES2266828T3/es not_active Expired - Lifetime
- 2003-04-22 PL PL03371743A patent/PL371743A1/xx unknown
- 2003-04-22 OA OA1200400285A patent/OA12810A/en unknown
- 2003-04-22 TW TW092109359A patent/TW200306802A/zh unknown
- 2003-04-22 KR KR10-2004-7016923A patent/KR20040104585A/ko not_active Application Discontinuation
- 2003-04-22 BR BR0309439-1A patent/BR0309439A/pt not_active IP Right Cessation
- 2003-04-22 IL IL16410903A patent/IL164109A0/xx unknown
- 2003-04-22 AP APAP/P/2004/003160A patent/AP2004003160A0/en unknown
- 2003-04-22 WO PCT/SE2003/000634 patent/WO2003090734A1/en active IP Right Grant
- 2003-04-22 AU AU2003237724A patent/AU2003237724A1/en not_active Abandoned
- 2003-04-22 MX MXPA04010472A patent/MXPA04010472A/es not_active Application Discontinuation
- 2003-04-22 DE DE60307258T patent/DE60307258T2/de not_active Expired - Fee Related
- 2003-04-22 CN CNA038090643A patent/CN1646110A/zh active Pending
- 2003-04-22 AT AT03736380T patent/ATE334665T1/de not_active IP Right Cessation
- 2003-04-22 EA EA200401108A patent/EA200401108A1/ru unknown
-
2004
- 2004-09-20 IS IS7462A patent/IS7462A/is unknown
- 2004-10-14 MA MA27908A patent/MA27197A1/fr unknown
- 2004-10-19 NO NO20044449A patent/NO20044449L/no not_active Application Discontinuation
- 2004-10-21 HR HRP20040990 patent/HRP20040990A2/hr not_active Application Discontinuation
- 2004-10-21 EC EC2004005373A patent/ECSP045373A/es unknown
- 2004-10-22 TN TNP2004000212A patent/TNSN04212A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60307258T2 (de) | 2007-10-25 |
| HRP20040990A2 (en) | 2004-12-31 |
| WO2003090734A1 (en) | 2003-11-06 |
| EP1496882A1 (en) | 2005-01-19 |
| CA2483092A1 (en) | 2003-11-06 |
| EP1496882B1 (en) | 2006-08-02 |
| ECSP045373A (es) | 2004-11-26 |
| MA27197A1 (fr) | 2005-01-03 |
| DE60307258D1 (de) | 2006-09-14 |
| JP2005535578A (ja) | 2005-11-24 |
| NO20044449L (no) | 2004-10-26 |
| BR0309439A (pt) | 2005-02-15 |
| PL371743A1 (en) | 2005-06-27 |
| AU2003237724A1 (en) | 2003-11-10 |
| ATE334665T1 (de) | 2006-08-15 |
| KR20040104585A (ko) | 2004-12-10 |
| EA200401108A1 (ru) | 2005-06-30 |
| AP2004003160A0 (en) | 2004-12-31 |
| MXPA04010472A (es) | 2005-07-14 |
| TNSN04212A1 (fr) | 2007-03-12 |
| ES2266828T3 (es) | 2007-03-01 |
| IS7462A (is) | 2004-09-20 |
| IL164109A0 (en) | 2005-12-18 |
| TW200306802A (en) | 2003-12-01 |
| US7005449B2 (en) | 2006-02-28 |
| CN1646110A (zh) | 2005-07-27 |
| US20030199582A1 (en) | 2003-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA12810A (en) | Tolterodine 12 salts. | |
| US20050261328A1 (en) | Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents | |
| JP2005533860A5 (ko) | ||
| EP3287438A1 (en) | Choline salt of an anti-inflammatory substituted cyclobutenedione compound | |
| PT1461306E (pt) | Compostos de amónio quaternário | |
| TWI589305B (zh) | 用於經口投藥之包含安布索、左旋羥丙哌嗪及緩衝劑的液體調配物以及製備其之方法 | |
| EP1773307B1 (en) | Compound formulations of 2-amino-1,3-propanediol compounds | |
| US6538035B2 (en) | Use of tolterodine to treat asthma | |
| WO2003039464A2 (en) | Antimuscarinic aerosol | |
| JP4278652B2 (ja) | 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物 | |
| CZ111897A3 (cs) | Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek | |
| WO2023213182A1 (zh) | 一种卡瑞斯汀的盐及其用途 | |
| JP2006504768A (ja) | 四級アンモニウム化合物 | |
| JP2006506402A (ja) | 四級アンモニウム化合物およびその抗ムスカリン薬としての使用 | |
| WO2008006295A1 (fr) | Phenylethanol amines optiquement actifs et procédé d'élaboration | |
| KR20060023997A (ko) | 신경보호 약제 조성물을 제조하기 위한바이시클로〔2.2.1〕헵탄 유도체의 용도 | |
| KR20210152280A (ko) | 몬테루카스트와 레보세티리진을 포함하는 안정성이 향상된 단일 정제 및 이의 제조방법 | |
| CA2503654A1 (en) | Quinuclidinium derivatives as antimuscarinic agents | |
| TW201838629A (zh) | 用於預防近視、治療近視及／或預防近視增長之包含蕪地銨作爲活性成分的藥劑 | |
| AU2022365423A1 (en) | Oral formulation | |
| KR20240027792A (ko) | 케타민 유도체의 약제학적 조성물 및 경구 투여 형태 | |
| WO2005041969A1 (en) | Pharmaceutical product comprising a beta-2 adrenergic agonist and an h1-receptor antagonist | |
| JP2007509868A (ja) | 緊張性尿失禁及び／又は混合型尿失禁治療用医薬組成物 | |
| JPH03130218A (ja) | 子宮弛緩剤及び膀胱弛緩剤 | |
| WO2005077371A1 (en) | Use of levocetirizine for the preparation of a drug |